Clincosm LogoSign in Get a demo

candidiasis, chronic mucocutaneous

Showing 1 - 1 of 1
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Candidiasis, Chronic Mucocutaneous Trial run by the Matinas BioPharma Nanotechnologies, Inc. (Amphotericin B)

Completed
  • Candidiasis, Chronic Mucocutaneous
  • Amphotericin B
  • Bethesda, Maryland
    National Institute of Allergy and Infectious Disease (NIAID)
Aug 17, 2022